特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
966291

ヒトマイクロバイオームの世界市場:将来予測 (2027年まで)、製品別・疾患別・用途別・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響

Human Microbiome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product, Disease, Application, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 207 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ヒトマイクロバイオームの世界市場:将来予測 (2027年まで)、製品別・疾患別・用途別・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響
出版日: 2020年09月24日
発行: The Insight Partners
ページ情報: 英文 207 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトマイクロバイオームの市場規模は、2019年には3億5629万米ドル、2027年には18億7353万米ドルに達すると予想されています。また、2020年から2027年にかけて23.6%のCAGRで成長すると推定されています。

当レポートでは、世界のヒトマイクロバイオームの市場について分析し、市場の基本構造や背景事情 (主な促進・抑制要因など)、市場規模の動向見通し (今後9年間分)、製品別・疾患別・用途別・地域別の詳細動向、主要企業のプロファイルと戦略展開状況、昨今の新型コロナウイルス感染症 (COVID-19) に伴う影響、といった情報を取りまとめてお届けいたします。

目次

第1章 イントロダクション

第2章 ヒトマイクロバイオーム市場:分析概要

第3章 分析手法

第4章 世界のヒトマイクロバイオーム市場:市場環境

  • 概要
  • 専門家の見解

第5章 ヒトマイクロバイオーム市場:主な市場力学

  • 主な市場促進要因
  • 主な市場抑制要因
  • 主な市場機会
  • 今後の動向
  • 影響分析

第6章 ヒトマイクロバイオーム市場:世界市場の分析

  • 市場収益額とその予測
  • 市場規模の予測と分析:地域別
  • 主要企業の市場ポジショニング

第7章 ヒトマイクロバイオーム市場:製品別の分析

  • 概要
  • ヒトマイクロバイオーム市場:製品別シェア (2019年、2027年)
  • 食品
  • 医療食品
  • プロバイオティクス
  • 薬物
  • 診断装置
  • サプリメント

第8章 ヒトマイクロバイオーム市場:疾患別の分析

  • 概要
  • ヒトマイクロバイオーム市場:疾患別シェア (2019年、2027年)
  • 糖尿病
  • がん
  • 自己免疫疾患
  • 肥満症
  • 精神障害
  • その他

第9章 ヒトマイクロバイオーム市場:用途別の分析

  • 概要
  • ヒトマイクロバイオーム市場:用途別シェア (2019年、2027年)
  • 診断
  • 治療

第10章 ヒトマイクロバイオーム市場:地域別の分析と予測

  • 北米市場
  • 欧州市場
  • アジア太平洋市場
  • 中東・アフリカ市場
  • 中南米市場

第11章 世界のヒトマイクロバイオームにおけるCOVID-19感染拡大の影響

  • 北米:COVID-19感染拡大の影響分析
  • 欧州:COVID-19感染拡大の影響分析
  • アジア太平洋:COVID-19感染拡大の影響分析
  • 他の国々 (RoW):COVID-19感染拡大の影響分析

第12章 ヒトマイクロバイオーム市場:業界情勢

  • ヒトマイクロバイオーム市場における成長戦略 (2015年~2020年)
  • 有機的発展
  • 無機的発展

第13章 企業プロファイル

  • ENTEROME
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX
  • MaaT Pharma
  • ELIGO BIOSCIENCE
  • AOBiome
  • Kaleido Biosciences, Inc.
  • Seres Therapeutics
  • Merck & Co., Inc.

第14章 付録

図表

List Of Tables

  • Table 1. North America Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Europe Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Germany Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Germany Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 19. United Kingdom Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 20. UK: Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million).
  • Table 21. UK: Human Microbiome Market, Usability - Revenue and Forecast to 2027 (USD Million)
  • Table 22. France Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 23. France Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Spain Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Italy Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Italy Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Italy Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Asia Pacific Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia Pacific Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Asia Pacific Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 34. China Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 36. China Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Japan Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Japan Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 40. India Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 41. India Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 42. India Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 43. South Korea Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 45. South Korea Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Australia Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Australia Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Middle East & Africa Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East & Africa Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
  • Table 51. Middle East & Africa Human Microbiome Market, by Application - Revenue and Forecast to 2027(USD Million)
  • Table 52. Saudi Arabia Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 53. Saudi Arabia Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Saudi Arabia Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 55. UAE Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 56. UAE Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 57. UAE Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Africa Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Africa Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South and Central America Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Brazil Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Brazil Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Argentina Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Argentina Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Recent Product Launches & Approvals in the Human Microbiome Market
  • Table 71. RecentEXPANSIONS in the Human Microbiome Market
  • Table 72. Patent and License Organic Growth Strategies in the Human Microbiome Market
  • Table 73. Recent Acquisitions in the Human Microbiome market
  • Table 74. Recent Partnerships & Collaborations in the Human Microbiome market
  • Table 75. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
  • Table 76. Glossary of Terms, Human Microbiome Market

List Of Figures

  • Figure 1. Human Microbiome Market Segmentation
  • Figure 2. Human Microbiome Market Segmentation, By Region
  • Figure 3. Human Microbiome Market Overview
  • Figure 4. Probiotics Segment Held Largest Share of Human Microbiome Market
  • Figure 5. Asia-Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Human Microbiome Market, by Geography (US$ Million)
  • Figure 7. Global Human Microbiome Market - Leading Country Markets (US$ Million)
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Asia pacific PEST Analysis
  • Figure 11. Middle East and Africa PEST Analysis
  • Figure 12. South and Central America PEST Analysis
  • Figure 13. Human Microbiome Market Impact Analysis of Driver and Restraints
  • Figure 14. Global Human Microbiome Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 15. Global Human Microbiome Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 16. Market Positioning Of Key Players In Global Human Microbiome Market
  • Figure 17. Human Microbiome Market Revenue Share, by Product (2019 and 2027)
  • Figure 18. Foods: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Medical Food: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Probiotics: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Drugs: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Diagnostic Devices: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Supplements: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
  • Figure 25. Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Human Microbiome Market Revenue Share, by Application(2019 and 2027)
  • Figure 32. Diagnostics: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Therapeutics: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. North America: Human Microbiome Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 35. North America Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
  • Figure 36. North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
  • Figure 37. US: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Canada: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Mexico: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Europe: Human Microbiome Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 41. Europe Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
  • Figure 43. Germany: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. UK: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. France: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Spain: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Italy: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia Pacific: Human Microbiome Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 49. Asia Pacific Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
  • Figure 50. China: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Japan: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. India: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. South Korea: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Australia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Human Microbiome Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. Middle East & Africa Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Human Microbiome Market, by Country, 2019 & 2027 (%)
  • Figure 58. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. UAE: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. South Africa: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Human Microbiome Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. South and Central America Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Human Microbiome Market, by Country, 2019 & 2027 (%)
  • Figure 64. Brazil: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Argentina: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Rest of the World Market
  • Figure 70. Growth Strategies in the Human Microbiome Market, 2015-2020
  • Figure 71. Organic Growth Strategies in the Human Microbiome Market, 2015-2020
  • Figure 72. Inorganic Growth Strategies in the Endoscopy Device Market, 2015-2018
目次
Product Code: TIPBT00002233

Title:
Human Microbiome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Devices, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography.

The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027.

The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. On the other hand, strict government guidelines and lack of knowledge and detailed examination are likely to have a negative impact on the growth of the market in the coming years.

Humans usually coexist with the diverse microbial species living within and over humans. Various recent scientific studies have proven that the microbial community essentially acts like an organ of the body that plays a crucial role in human disease management and physiology. Various basic and translational research efforts have been initiated that focuses on deciphering mechanisms of the microbiome function and the ways that it benefits the human health. Various human medical conditions such as inflammatory bowel diseases and obesity have been closely associated with and are thought to be influenced by the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements, and foods that contain live microbes have been studied thoroughly to assess their effects on human health.

The Human Microbiome Project of the National Institutes of Health in the US and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to diseases. Large governmental research initiatives including the Human Microbiome Project in the U.S. and the MetaHIT Project in Europe have accelerated research on the human microbiome.

Based on product, the human microbiome market is segmented into probiotics, foods, prebiotics, medical foods, diagnostic devices, drugs, and supplements. In 2019, the probiotics segment held the largest share of 24.73% of the human microbiome market, by product. This segment is also expected to dominate the market in 2027 owing to increasing health concerns; growing awareness regarding the relation of nutrition, diet, and health; and increasing probiotics market penetration in dairy and other foods. Furthermore, the prebiotics segment is anticipated to witness the fastest growth rate during the forecast period.

Several players have observed good demand for human microbiome based products during the initial period of COVID-19, particularly from the food & beverages industry. In addition, researchers are studying the correlation between gut bacteria and COVID-19. Many researchers have showcased gut bacteria's implication in different health conditions, from type 2 diabetes to depression. However, the obstacles in supply chains and distribution networks resulting in unavailability of human microbiome based products in various parts of the world are likely to hamper the growth of the market in 2020.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union, Organization for Economic Co-operation and Development, Canadian Institute for Advanced Research, Biotechnology Industry Research Assistance Council and American Cancer Society (ACS) are a few of the essential secondary sources referred to while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Human Microbiome Market - By Product
    • 1.3.2 Global Human Microbiome Market - by Disease
    • 1.3.3 Global Human Microbiome Market - by Application
    • 1.3.4 Global Human Microbiome Market - By Geography

2. Human Microbiome Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Human Microbiome Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 North America - PEST Analysis
    • 4.1.2 Europe- PEST Analysis
    • 4.1.3 Asia Pacific- PEST Analysis
    • 4.1.4 Middle East And Africa- PEST Analysis
    • 4.1.5 South and Central America - PEST Analysis
  • 4.2 Expert Opinions

5. Human Microbiome Market- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Incidence of Lifestyle Diseases
    • 5.1.2 Increasing Focus On Human Microbiome Therapies
    • 5.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
  • 5.2 Key Market Restraints
    • 5.2.1 Strict Government Guidelines
    • 5.2.2 Lack of Knowledge and Detailed Examination
  • 5.3 Key Market Opportunities
    • 5.3.1 New Drug Requirements for Faecal Microbiota
    • 5.3.2 Emerging Nations
  • 5.4 Future Trends
    • 5.4.1 The Human Microbiome - A New Frontier in Drug Discovery
  • 5.5 Impact analysis

6. Human Microbiome Market - Global Analysis

  • 6.1 Global Human Microbiome Market Revenue Forecast and Analysis
  • 6.2 Global Human Microbiome Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Human Microbiome Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Human Microbiome Market Revenue Share, by Product (2019 and 2027)
  • 7.3 Foods
    • 7.3.1 Overview
    • 7.3.2 Foods: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Medical Food
    • 7.4.1 Overview
    • 7.4.2 Medical Food: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Probiotics
    • 7.5.1 Overview
    • 7.5.2 Probiotics: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Drugs
    • 7.6.1 Overview
    • 7.6.2 Drugs: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Diagnostic Devices
    • 7.7.1 Overview
    • 7.7.2 Diagnostic Devices: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Supplements
    • 7.8.1 Overview
    • 7.8.2 Supplements: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)

8. Human Microbiome Market Analysis - By Disease

  • 8.1 Overview
  • 8.2 Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
  • 8.3 Diabetes
    • 8.3.1 Overview
    • 8.3.2 Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Cancer
    • 8.4.1 Overview
    • 8.4.2 Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Obesity
    • 8.6.1 Overview
    • 8.6.2 Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 Mental Disorders
    • 8.7.1 Overview
    • 8.7.2 Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.8 Others Market
    • 8.8.1 Overview
    • 8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Human Microbiome Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Human Microbiome Market Revenue Share, by Application(2019 and 2027)
  • 9.3 Diagnostics
    • 9.3.1 Overview
    • 9.3.2 Diagnostics:Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Therapeutics
    • 9.4.1 Overview
    • 9.4.2 Therapeutics:Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)

10. Human Microbiome Market Analysis and Forecasts To 2027 Geographical Analysis

  • 10.1 North America: Human Microbiome Market
    • 10.1.1 Overview
    • 10.1.2 North America: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Human Microbiome Market, by Product, 2018-2027 (USD Million)
    • 10.1.4 North America: Human Microbiome Market, by Disease, 2018-2027 (USD Million)
    • 10.1.5 North America: Human Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.1.6 North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.1.7.3 US: Human Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.1.7.4 US: Human Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.1.8 Canada: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Human Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.1.8.4 Canada: Human Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.1.9 Mexico: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Human Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Human Microbiome Market, by Application, 2018-2027 (USD Million)
  • 10.2 Europe: Human Microbiome Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Europe Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 Germany Human Microbiome Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UKHuman Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 UK: Human Microbiome Market, Usability - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 France Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 Spain Human Microbiome Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy Human Microbiome Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy Human Microbiome Market, by Disease - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Italy Human Microbiome Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Human Microbiome Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific: Human Microbiome Market, by Product, 2018-2027 (USD Million)
    • 10.3.4 Asia Pacific: Human Microbiome Market, by Disease, 2018-2027 (USD Million)
    • 10.3.5 Asia Pacific: Human Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.3.6 Asia Pacific: Human Microbiome Market, by Country, 2018 & 2027 (%)
    • 10.3.7 China: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.3.7.3 ChinaHuman Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.3.7.4 China Human Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.3.8 Japan: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.3.8.3 JapanHuman Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.3.8.4 JapanHuman Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.3.9 India: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.3.9.3 IndiaHuman Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.3.9.4 IndiaHuman Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.3.10 South Korea: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.3.10.3 South KoreaHuman Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.3.10.4 South KoreaHuman Microbiome Market, by Application, 2018-2027 (USD Million)
    • 10.3.11 Australia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia: Human Microbiome Market, by Product, 2018-2027 (USD Million)
      • 10.3.11.4 Australia Human Microbiome Market, by Disease, 2018-2027 (USD Million)
      • 10.3.11.5 Australia Human Microbiome Market, by Application, 2018-2027 (USD Million)
  • 10.4 Middle East & Africa: Human Microbiome Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.4.6 Middle East & Africa: Human Microbiome Market, by Country, 2019& 2027 (%)
      • 10.4.6.1 Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.6.2 Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.6.3 Saudi Arabia Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.4.6.4 Saudi Arabia Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.4.6.5 Saudi Arabia Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.4.7 UAE: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 UAE: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 UAE Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 UAE Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 UAE Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.4.8 South Africa: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 South Africa: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 South Africa Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 South Africa Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 South Africa Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)
  • 10.5 South and Central America: Human Microbiome Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America Human Microbiome Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Human Microbiome Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.5.8 Argentina: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina Human Microbiome Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina Human Microbiome Market, by Disease- Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina Human Microbiome Market, by Application- Revenue and Forecast to 2027(USD Million)

11. Impact of COVID-19 Pandemic on Global Human Microbiome Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Human Microbiome Market - Industry Landscape

  • 12.1 Growth Strategies in the Human Microbiome Market, 2015-2020
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
    • 12.2.2 Product Launch & Approvals
    • 12.2.3 Expansion
    • 12.2.4 Patent and license
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
    • 12.3.2 Acquisitions
    • 12.3.3 Partnerships, Collaborations & Agreements
    • 12.3.4 Joint Ventures

13. Company Profiles

  • 13.1 ENTEROME
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Rebiotix Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Overview
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Yakult Honsha Co., Ltd.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Overview
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Osel Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product Portfolio
    • 13.4.5 Swot Analysis
    • 13.4.6 Key Developments
  • 13.5 Vedanta Biosciences, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Information
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Synthetic Biologics, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Information
    • 13.6.4 Product Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 DuPont
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 BiomX
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Information
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 MaaT Pharma
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ELIGO BIOSCIENCE
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 AOBiome
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Kaleido Biosciences, Inc.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Seres Therapeutics
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Merck & Co., Inc.
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.